Dr. Jacque Sokolov and Dr. Lishan Aklog discuss the value of  forming a strategic board of directors in early-stage companies in the February 2024 AZBioPEERS webcast.Continue reading→

Higher education executive Heather Carter, UArizona biomedical engineer Jennifer Barton to serve as chair, vice chairContinue reading→

Spend eight weeks working side-by-side with some of the world’s most talented scientists, clinicians and researchers in an environment devoted to neuroscientific biomedical research and clinical care. Banner-ASU Neuroscience Scholars is a paid, eight-week training program open to top-achieving college undergraduate and graduate science students.Continue reading→

Continue reading→

Parkinson’s disease, the second most common type of progressive dementia after Alzheimer’s disease, affects nearly 1 million people in the U.S. and an estimated 10 million individuals worldwide. Each year, close to 90,000 new cases of Parkinson’s disease are diagnosed in the U.S.Continue reading→

Leader in Medical Technology Joins Team to Extend Reach of GammaTile® to More Patients with Brain TumorsContinue reading→

Project in Phoenix metro area is first to look at fungus risk exposure in the airContinue reading→

TUCSON, ARIZONA – February 13, 2024 – Avery Therapeutics, Inc. (“Avery”), a privately held, pre-clinical stage therapeutics company, proudly announces the successful qualification of their in-house cGMP pilot manufacturing facility for Phase I production in Tucson, AZ.Continue reading→

Arizona business leaders Chris Camacho and Adam Goodman—the heads of Greater Phoenix Economic Council and Goodmans, respectively—have been elected to the Flinn Foundation board of directors.Continue reading→

Bayer’s Expert Mondays – Knowledge Sharing to Empower Your Innovation Journey and Meet & Greet with Bayer Pharma Scouts.Continue reading→